A Single Center Four Part Study in Healthy Adult Subjects to Evaluate: the Safety, Tolerability and Pharmacokinetics of a Single Oral Dose and Repeat Escalating Oral Doses of GSK945237; the Effect of Linezolid on Hematology Safety Parameters; and the Effects of GSK945237 and Moxifloxacin on QTc.
PHASE1
GSK945237 belongs to the Bacterial Type II Topoisomerase Inhibitor (BTI) cl...
Evaluation of a Personalized Normative Feedback Repeatedly Delivered Via a Mobile Application After a Brief Therapeutic Intervention on Alcohol-related Risks:
NA
BTI (Brief Therapeutic Intervention) motivates individuals admitted to ED (...
A Dose-Ranging Study Evaluating the Efficacy, Safety, and Tolerability of GSK2140944 in the Treatment of Uncomplicated Urogenital Gonorrhea Caused by Neisseria Gonorrhoeae
PHASE2
GSK2140944 has demonstrated in vitro activity against Neisseria (N.) gonorr...
The Effect of a Self-rehabilitation Program in Addition to Usual Treatment for Spasticity on Impairment and Activity Limitation in Patients With Spastic Hemiparesis Following Stroke
PHASE3
The addition of a self-rehabilitation program to repeated Botulinum Toxin I...